The new 2020 Glaucoma Surgical Device Market Report provides an analysis of COVID-19 impact on 2020 sales and expected recovery in 2021 and through 2025. The report focuses on next-generation MIGS that target the suprachoroidal drainage space and characterizes a recent trend toward surgical device mix-and-match strategies to achieve trab-like low IOP outcomes.
It also tracks the progress being made in sustained drug delivery devices, adds a listing of 14 early-stage glaucoma surgery development projects, and describes the impact of just-approved MIGS designed for later stages of glaucoma. Additionally, the report details a number of recently announced mergers and acquisitions and their expected market impact.
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.